COMP <GO>
VTRS vs ASND // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Viatris Inc. (NASDAQ) VS. Ascendis Pharma A/S Ordinary Share (NASDAQ) • 15-METRIC TALLY: VTRS 3
— ASND 8
■ METRIC PARITY
LAST: $19.04 (-0.86%) • MKT CAP: $21.86B
options-implied-move
—
LAST: $251.27 (-0.68%) • MKT CAP: $16.55B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VTRS VS. ASND)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VTRS | ASND | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -8.10% | 9.90% | -18.00 | ASND | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 21.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 8.78% | 2.21% | +6.57 | VTRS | /fcf-yield <GO> |
| Operating Margin | -18.70% | 13.90% | -32.60 | ASND | /operating-margins <GO> |
| Net Profit Margin | -14.60% | 10.90% | -25.50 | ASND | /net-margins <GO> |
| Revenue Growth (YoY) | -3.00% | 12.10% | -15.10 | ASND | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.81 | 3.74 | -2.93 | ASND | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | ASND | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.5 | 63.3 | -0.80 | ASND | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.15 | 0.98 | +0.17 | VTRS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.0x | 27.6x | +5.40 | ASND | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.86B | $16.55B | $5.31B | VTRS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VTRS REV | ASND REV | VTRS GROSS % | ASND GROSS % | VTRS FCF | ASND FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $14.25B | — | 35.2% | — | $1.94B | — |
| FY 2024 | $14.69B | — | 38.3% | — | $1.98B | — |
| FY 2023 | $15.39B | — | — | — | $2.21B | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VTRS // BETA 1.15
ASND // BETA 0.98